Petra Denig is professor in Drug Utilization Quality at the Department of Clinical Pharmacy and Pharmacology of the University Medical Center Groningen, the Netherlands. Her research aims at developing innovative strategies and insights that contribute to optimal use of medicines in practice. The focus is on the treatment of chronic diseases, particularly diabetes and cardiovascular diseases, and management of polypharmacy, including deprescribing.
Prof. Denig is projectleader of the Groningen Initiative to Analyse Type 2 diabetes Treatment (GIANTT) project, hosting a research database with longitudinal data obtained during routine care from >60.000 patients with type 2 diabetes. Furthermore, Prof. Denig is member of the Expertgroup Monitor Prescription Behavior General practitioners, the Working Group Prescription Feedback of the Dutch Institute for Rational Use of Medicine, and member of the Medication Adherence Expertise Center of the northern Netherlands (MAECON). She is also expert member for the module Deprescribing of the Dutch Guideline Polypharmacy in the Elderly and member of the steering committee of the Northern European Researchers in Deprescribing (NERD) network.